Short answer · Medically reviewed summary · Last updated: 2026-05-08
Kernicterus is a rare, preventable form of permanent brain damage caused by extremely high levels of bilirubin in a newborn’s blood, which leads to toxic deposits in specific areas of the brain. While initial jaundice is common in newborns, Kernicterus occurs when this bilirubin crosses the blood-brain barrier, resulting in lasting neurological impairment. What causes Kernicterus? The underlying mechanism of Kernicterus involves the accumulation of unconjugated bilirubin, a yellow pigment produced during the normal breakdown of red blood cells.
What is Kernicterus
What is Kernicterus? Plain-language, medically reviewed definition plus the lived reality told by patients.
Kernicterus is a rare, preventable form of permanent brain damage caused by extremely high levels of bilirubin in a newborn’s blood, which leads to toxic deposits in specific areas of the brain. While initial jaundice is common in newborns, Kernicterus occurs when this bilirubin crosses the blood-brain barrier, resulting in lasting neurological impairment.
What causes Kernicterus?
The underlying mechanism of Kernicterus involves the accumulation of unconjugated bilirubin, a yellow pigment produced during the normal breakdown of red blood cells. In newborns, if the liver cannot process this pigment quickly enough, it builds up in the bloodstream. When levels reach a critical threshold, this neurotoxic substance crosses into the brain, specifically damaging the basal ganglia and brainstem nuclei, which are vital for motor control and hearing.
Who is typically affected by Kernicterus?
Kernicterus almost exclusively affects newborns, typically within the first week of life. It is considered an extremely rare condition in developed countries due to routine screening and effective phototherapy treatments. However, the risk remains higher in infants with:
- Severe Rh or ABO blood type incompatibility between mother and baby.
- Glucose-6-phosphate dehydrogenase (G6P) deficiency.
- Premature birth, which makes the infant more vulnerable to bilirubin toxicity.
- Delayed diagnosis of neonatal jaundice.
How is Kernicterus classified?
Clinicians often distinguish between acute bilirubin encephalopathy (the initial, potentially reversible phase) and Kernicterus (the chronic, permanent phase). The progression typically follows these stages:
- Acute Phase: Symptoms include extreme lethargy, poor feeding, and high-pitched crying.
- Intermediate Phase: Infants may experience arching of the back and neck (opisthotonus) and fever.
- Chronic Phase (Kernicterus): Characterized by permanent movement disorders, such as athetoid cerebral palsy, sensorineural hearing loss, and upward gaze paralysis.
What differentiates Kernicterus from other conditions?
Unlike common neonatal jaundice, which is a benign and transient condition, Kernicterus represents a medical emergency. It is distinct from other forms of cerebral palsy because the damage is specifically localized to the auditory and motor pathways of the brain, rather than being a generalized developmental issue.
Next steps
- Consult your pediatrician immediately if you observe extreme jaundice or lethargy in your newborn.
- Join our community of 146 members at DiseaseMaps.org to share experiences and connect with others affected by Kernicterus.
- Request a bilirubin screening if your newborn appears unusually yellow or is not feeding well.
Medical disclaimer: This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Kernicterus overview.
- Orphanet: Rare diseases database entry for Kernicterus.
- American Academy of Pediatrics (AAP) Clinical Practice Guidelines on the Management of Hyperbilirubinemia.
- PubMed/NCBI: Current research on bilirubin-induced neurologic dysfunction.
